Lavie Zmira sold $273K of VICR

Lavie Zmira sold 1,216 shares of VICOR CORP (VICR) at $224.72 ($0.27M total) on 2026-07-23.

Original reporting
SEC EDGAR · Lavie Zmira
Published Jul 27, 2026, 3:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 27, 2026, 3:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The filing discloses an open-market sale of 1,216 shares at $224.72/share, leaving the director with 0 shares, but provides no accompanying rationale or company performance update.

02

Market read

Traders may monitor for insider activity trends, but this single Form 4 sale is unlikely to drive a fundamental repricing without additional corroborating news.

03

What to watch

Check for clustering of insider transactions across multiple directors/officers and whether subsequent Form 4s show purchases or additional sales around the same period.

Relevance 4/10Novelty 3/10Timing: Filed 2026-07-27, disclosing a sale dated 2026-07-23.

Background

The article is a primary-source SEC Form 4 insider transaction for VICOR Corp, reported by director Lavie Zmira.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

Lavie Zmira, a VICOR Corp director, sold 1,216 shares in an open-market transaction for about $273.3K at $224.72/share.

Expected impact

Likely limited near-term impact; any effect would be sentiment-only unless follow-on filings show unusual patterns.

Evidence & confidence

Form 4 insider sales are common and this filing provides only transaction details, not earnings, guidance, or operational changes. The absence of a pre-arranged 10b5-1 plan can raise scrutiny, but the disclosed size and director role alone are insufficient to imply a fundamental shift.

Market effects

No direct sector read-through; this is company-specific insider transaction data only.

None indicated.

None indicated.

Counterpoint

The sale could be for personal liquidity needs and does not necessarily reflect negative expectations, especially given the small absolute share count.

Key entities

  • VICOR CORP

    Company whose director insider sale is disclosed on Form 4.

  • Lavie Zmira

    Director who sold 1,216 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VICRMed

VICR SWOT Analysis: Strong Revenue Growth and Patent Settlement

Vicor Corp (VICR) reported Q3 2026 revenue of $197.1M, up 78.5% YoY, driven by product sales and royalty revenue. Gross margin increased to 68.3%. The company has a strong order backlog of $406M but faces valuation concerns and customer concentration risks. It has growth opportunities in EVs and renewable energy. VICR's GF Score is 82/100, with high growth and profitability ratings but low valuation.

$VICRHigh

VICR Stock Surges On Blowout Q3 And Aggressive Capacity Bet

Vicor Corporation (VICR) stock rose 12.95% after reporting Q3 2026 revenue of $197.1M, up 78.5% YoY, with gross margin at 68.3%. The company's backlog and operating cash flow increased, driven by AI and high-performance systems demand. VICR is expanding capacity and faces an ITC investigation. Analysts raised price targets to $350-$360.

$VICRHighAI 8/10

Why is Vicor stock climbing today?

Vicor Corporation (VICR) stock rose 2.6% in morning trading, extending gains after its Q3 2026 earnings beat expectations. Revenue was $197.1M, up 78.5% YoY, with adjusted EPS of $1.33. Gross margin expanded to 68.3%, and the order backlog grew 166% YoY to $406M. Analysts maintained Buy ratings with price targets of $350 and $375. The stock traded at $209.36, above its 52-week low of $79 but below its high of $382.65.